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We investigated the role of T cell cytotoxicity 
inducing  factor 1 (TCF1) in  the  induction  of a  cyto- 
toxic T cell response. We found  that  help-deficient 
thymocyte cultures supplied  with  saturating 
amounts of  purified IL 2 did  not  develop CTL in  a 5- 
day culture, The expression of cytotoxicity was  de- 
pendent on the  addition  of TCFl derived  from  the T 
cell hybridoma K15. TCFl also induced prolifera- 
tion of thymocytes  in  the  presence of IL 2. Only the 
PNA- thymocyte  subpopulation  responded to TCFl 
with  proliferation  and  cytotoxicity  in the presence 
of IL 2. The  monokine IL 1 also induced  proliferation 
in this subpopulation  but  failed to induce  cytotox- 
icity. IL 1 was  further  distinguished  from TCFl by 
inhibition of IL 1-induced  but  not  TCF1-induced  pro- 
liferation by  anti-IL 1  antibodies. In addition,  using 
anti-IL 2 receptor  antibodies (AMT 13). we showed 
that TCFl in the presence of 1L 2 substantially 
increased IL 2 receptor  expression  in  thymocytes. 
IL 1 had  the  same  effect  on  induction of IL 2 receptor 
expression as TCF1. Because  some effects of IL 1 
and TCFl are distinct and  some  overlap,  we discuss 
whether IL 1 and TCFl induce  different subsets of 
PNA- thymocytes. 
The development of mature cytotoxic T lymphocytes 
(CTL)* from immature CTL precursors (CTLp) is a com- 
plicated process that involves the activity of several cell 
types and soluble mediators. la+ macrophages process 
antigen  and  secrete  interleukin 1 (IL 1). IL 1 is essential 
for the activation of T  helper  cells (1) .  Activated T  helper 
cells secrete  interleukin  2 (IL 2). IL 2  stimulates  activated 
CTLp to proliferate and to differentiate to competent 
cytotoxic T cells (2). However, investigators from several 
laboratories  have reported that IL 2  alone does not induce 
the differentiation of CTLp to mature CTL (3-12). We 
previously described a model system  for CTLp differen- 
tiation involving at least two other  lymphokines and IL 2 
with  thymic  T cells used as  the lymphokine  responder 
population. Most murine  thymocytes 1 )  are immunologi- 
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cally immature (1 3, 14),  2)  are cortisone sensitive, 3) bind 
peanut agglutinin (PNA), 4)  express high levels of Thy-1 
and TL antigens  on  their  surface,  and 5) are Lyt-1+2+3+ 
(1 5, 16).  The  cortisone-resistant  subset of small  thymo- 
cytes (5 to 10%). however, resembles  mature  peripheral 
T cells functionally and phenotypically (1 7). These cells 
1 )  are not agglutinated by  PNA (14,  18),  2) exhibit  marked 
proliferation in the presence of mitogen and  either IL 1 
or IL 2 (6, 19). and 3) are stimulated by IL 1 alone to 
produce IL 2 and to undergo significant proliferation (1 9). 
In contrast,  the PNA+ thymocytes do not produce IL 2 
upon stimulation  with IL 1 and mitogen and  are therefore 
not the target cells for IL 1 -mediated responsiveness (19). 
We reinvestigated CTLp differentiation by using limit- 
ing numbers of unfractionated  thymic  responder cells in 
help-deficient cultures. Our experiments showed that  in 
addition to IL 2, the generation of cytotoxic responses by 
PNA- thymocytes was strictly  dependent on the presence 
of T cell cytotoxicity-inducing factor (TCF1) (7). TCFl 
could not be replaced by IL 1 or interferon-? (IFN-7). 
However, proliferation of PNA- thymocytes in the pres- 
ence of 1L 2 was induced by  TCF 1 as well as by IL 1 .  Most 
important,  stimulation of thymocytes  with IL 2  plus  TCFl 
induced expression of IL 2  receptors.  These data reinforce 
the role of TCFl as  an essential lymphokine for the early 
induction of CTLp differentiation. 
MATERIALS AND METHODS 
Mice. Male C3H/HeJ mice were purchased from The Jackson 
Laboratory, Bar Harbor, ME. C3H/Tif were  bred  in  our  own  colony. 
All animals  were  used at 4 to 9 wk of age. 
(GIBCO; powdered  media) with  L-glutamine (2 x M) and  supple- 
Culture  medium. The culture  medium used was RPMI 1640 
mented with 10% heat-inactivated fetal calf serum (FCS), HEPES 
(0.02 M). 2-mercaptoethanol  (4 x M). and  gentamicin (50 pg/ 
ml). 
Lymphokine  preparations. Concanavalin A- (Con A; Pharmacia. 
Uppsala,  Sweden)  induced  supernatants  were  prepared by conven- 
adjusted  to lo7 cells/ml  in  culture  medium  and  incubated  for  24  hr 
tional methods. Single cell suspensions from mouse spleens were 
with 5 pg Con  A/ml in humidified air plus 5% COz. All preparations 
were  stored a t  4°C. 
Lymphokine  preparations  prepared b y  stimulation  with a Con 
containing  10 pg Con A/ml.  After 5 to 6 hr  the  cells  were  washed 
A pulse. Spleen cells (1 07/ml] were incubated in culture medium 
three  times  with  culture  medium.  The  cells  were  readjusted  to lo7/ 
ml and  cultured  in Con A-free  culture  medium  for  24  hr  at  37°C  in 
humidified air plus 5% COz. The cellfree supernatants contained 
less than 0.01 pg/ml Con A as measured by using  radiolabeled Con 
A (Amersham. U. K.). 
Absorption of IL 2. Con A-induced supernatants  were  depleted of 
IL 2 by absorption  with  cells  from a n  IL 2 receptor  bearing  long-term 
added to lo5 W-2 cells (7) and incubated for 48   hr   a t  37°C. The 
T cell line (W-2). One  milliliter of Con A-induced  supernatant  was 
cellfree supernatant  was dialyzed against  culture  medium  and  again 
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incubated  for 48  hr with IO5 W-2 cells per milliliter. The  Supernatant 
was  again dialyzed against  culture medium and  contained  less  than 
0.01 U/ml of IL 2  activity. 
preparation of T C F l  from T cell  hybridoma cells. K15 T 
hybridoma  cells (20) were suspended at  a density of lo6 CellS/ml in 
serum-free medium, and Con A (Serva. Heidelberg, F. R.  G.) was 
added to a final concentration of 20 pg/ml. The suspension was 
distributed  into  5-ml polypropylene tubes  at 1 ml and  was  incubated 
for 4 hr   a t  37°C. The cells  were then  washed  three  times,  and  the 
supernatants were removed by aspiration. The cells were resus- 
pended in 1 ml of serum-free medium and  incubated  for  24  hr in 
and FCS was added to a final concentration of 10%. They were 
humidified air  plus 5% COz. The  supernatants were then  harvested, 
filtered  and stored at  4°C. The activity was  stable for a t  least  2 mo. 
Preparation of IL 2. Partially  purified IL 2 was prepared as  de- 
a t  106/ml  in RPMI 1640  containing 0.5% heat-inactivated FCS. Ten 
scribed by Hilfiker et al. (21). EL-4 thymoma cells  were suspended 
nanograms per milliliter of phorbol myristic acetate (PMA) were 
added. and  the cells  were incubated for 48 hr.  The cellfree super- 
natant  was  concentrated on a n  Amicon Y M l O  membrane.  Proteins 
were precipitated with ammonium sulfate (80% saturation). The 
precipitate  was  washed once and dissolved in  water. After equilibra- 
tion with 0.8 M ammonium  sulfate  in 0.01 M phosphafe  buffer,  the 
sample  was applied on a phenyl-Sepharose  column  (Pharmacia).  The 
column was washed  with  2 vol of 0.64 M ammonium  sulfate  plus 
10%  ethanediol.  The IL 2-containing peak was finally eluted with 
40%  ethanediol  in  0.16 M ammonium  sulfate,  concentrated on a n  
Amicon PMlO membrane  and equilibrated  with  column buffer  (0.05 
M Tris-hydroxy-methylacetate. 0.1 M sodium  chloride, pH 7.2, con- 
taining 0.05% polyethylene glycol 6000). The material was then 
applied on a Sephadex  G-100  column,  and IL 2  activity  eluted  with 
an  apparent m.w. of 32,000. Peak fractions were pooled and dialyzed 
against  culture medium after  adding FCS to a final  concentration of 
10%. 
Assayfor IL I actiuity. IL 1 activity  was  measured  in  the C3H/ 
HrJ mouse thymocyte assay (22). One unit of  IL 1 per milliliter 
induced 50% of the  maximal thymocyte  proliferative response. 
Preparation of IL 1. IL 1 was prepared from P388D1 cells by 
following the  superinduction protocol of Mizel et  al.  (23). Briefly, 2 X 
lo6  adherent P388D1 cells  were cultured  in medium containing  10 
pg/mI PMA and 10 pglml  cycloheximide for 4 hr.  This medium was 
replaced by fresh medium containing 10 p g h l  actinomycin D. After 
1 hr  the cells  were washed  three  times  and were cultured overnight 
in  fresh medium. Cellfree supernatant  was collected, and protein 
was precipitated with ammonium sulfate (65% saturation). After 
extensive dialysis the sample was applied on a Sephadex G-100 
column. IL 1  activity  eluted  in one  peak a t  15.000  daltons.  The active 
fractions were pooled, dialyzed,  sterilized by filtration,  and kept a t  
-20°C. Purified IL 1 preparations were  generously provided by Dr. 
S .  Mizel. They  were  prepared  from superinduced P388D1 cells by gel 
filtration and immunoaffinity chromatography on goat anti-IL 1 
antibody coupled to  Sepharose 4B (23). 
Preparation of anti-IL 1 antibodies. Goat anti-IL 1 antibodies 
were also generously provided by Dr. S .  Mizel (23).  The IgG fraction 
was isolated on DEAE cellulose  ion-exchange chromatography  after 
adjusted to 5 to  10 mglml. 
ammonium sulfate precipitation. The protein concentration was 
Assay  for IL 2 activity. IL 2 in  supernatants  was  measured by 
the ability to support growth of the IL 2-dependent cell line W-2 (7). 
Thymidine  incorporation after a 20-hr  incubation  and a 4-hr pulse 
with 1 .O pCi of (methyl-3H]thymidine (3H-TdR; sp.  act. 50 Ci/mmol; 
Amersham  International Ltd., Amersham)  was  determined.  Results 
are  expressed as laboratory units as described by Farrar  et  al. (1). 
Assayfor IFN actiuity.  Interferon (IFN) titrations were  performed 
in  microtiter wells. L929 cells  in 0.2 ml of  RPMI 1640 + 5% FCS per 
well were  challenged with vesicular stomatitis  virus  (Indiana  strain). 
One unit was defined as the minimal amount of IFN capable of 
conferring protection to 50% of the cells.  One  microtiter unit per  0.2 
ml corresponds  to 2 NIH reference  units. All titers  are  expressed  in 
laboratory units. 
tured in a final volume of 0.16 ml medium and varying amounts of 
T celf cytotoxicity  assay. Thymic responder cells were co-cul- 
lymphokine  preparations  with 3 X lo5 glutaraldehyde-fixed, TNP- 
haptenated  syngeneic  spleen cells as stimulators. Cytotoxic activity 
was  measured on day 5 in a 4-hr 51Cr-release test by using 5 x IO3 
labeled TNP-modified tumbr  target cells  (L929  mouse  fibrosarcoma). 
The  data  are  presented as specific 51Cr release  (experimental release 
- spontaneous release)/(total release - spontaneous release) x 100. 
Spontaneous  release  was  determined in supernatants of assay wells 
to  which no  lymphokine preparations were added. Data are  the  mean 
of triplicate  cultures.  The  standard  error of the  mean  was  always 
less  than  2.5%. 
Thymocyte proliJeration. Thymocytes (1 to 3 x IO5 per culture) 
from C3H/HeJ mice were cultured in 0.2 ml medium for 3 days. 
Varying amounts of IL 2, 1L 1. IFN-y, or TCFl preparations were 
added to  these  cultures. 3H-TdR uptake  was  measured in a 5- to 12- 
hr pulse. and  results  are expressed in cpm of duplicate or triplicate 
cultures.The C3H/HeJ thymic  responder  cells  used  in these assays 
did not  respond to LPS (data not shown). 
Separation of PNA' and  PNA- thymocytes  byfluorescence-ac- 
tiuated  cell  sorting. Thymocytes were separated  after  staining with 
subagglutinating  concentrations of PNA-fluorescein isothiocyanate 
(PNA-FITC) (24). PNA-FITC at  a concentration of 5 pg lectin/ml 
medium was used  for staining lo7 cells/0.25 ml for 30 min at 4°C. 
Without washing,  the cells  were  diluted to 5 X lo6 cells/ml  for sorting 
in a fluorescence-activated cell sorter (Ortho Diagnostic System). 
The cells in channels 0 through 32 were collected as the PNA- 
fraction  and in channels 38 through 100 as the PNA' fraction. After 
sess  purity.  The sorted cell fractions were washed,  then resuspended 
sorting,  samples of fractionated thymocytes  were  reanalyzed to as- 
in  culture medium, and viable  cells  were  counted in a hemacytome- 
ter. 
1L 2 receptor determination. Monoclonal antibodies (AMT 13) 
from a rat hybridoma cell line directed against the murine IL 2 
receptor  were produced as described (25). Glutaraldehyde-fixed 
sheep  erythrocytes (5 x 1 06) were  added to triplicate cultures of 4 x 
lo5 thymocytes, and  the cells  were  kept  on ice for 30 min with or 
without 100 pl culture  supernatant  containing AMT 13 antibodies. 
fragments of a sheep  anti-rat IgG (100 pl of a 1 /10 diluted stock with 
After another incubation for 60 min on ice with '251-labeled F(ab'), 
specific  activity of 12 pCi/pg: Amersham  International Ltd.), the cells 
were washed: specific binding was determined and expressed as 
cpm. 
Recombinant murine 1FN-y (produced by Genentech, Inc.) was 
generously  supplied by Boehringer Ingelheim, and  recombinant  hu- 
man IL 2 (2 X lo5 U/ml) was obtained  from  Cetus Corp. The material 
was 98% pure  and  contained  0.02 ng/ml  endotoxin. 
RESULTS 
Requirement for TCFl  plus IL 2 for induction of CTL 
responses. Investigators from several  laboratories  have 
reported that  other lymphokines in addition to IL 2 are 
required for the induction of cytotoxic responses in lym- 
phocyte cultures (3-12). In our  system  TCFl  was  shown 
to be essential for the induction of cytotoxic responses. 
One hundred  thousand  thymic  responder cells, metabol- 
ically inactive  stimulator cells and  an excess IL 2 (>40 
U/culture) were used (7) (Figure 1). IL 1 or IFN--/ prepa- 
rations did not substitute for TCFl under these assay 
conditions. Control experiments  with 3H-labeled Con A 
showed that Con A that might have been carried over 
from TCFl preparations was not responsible for this 
effect (data  not  shown]. 
Induction of thymocyte  proliferation  with IL 2 plus 
either TCFl or IL 1. TCFl preparations from Con A- 
pulsed spleen or K15 hybridoma cells were tested for 
induction of IL 2-responsiveness  in C3H/HeJ thymocytes. 
Substantial proliferation was induced with  TCFl  in the 
absence of stimulator cells or mitogen when lo5 thymo- 
cytes were provided with saturating  amounts of IL 2 (1 00 
U/ml) (Figure 2). Likewise, IL 1 preparations induced 
thymocytes  to utilize IL 2 added to  the  cultures for prolif- 
eration.  The C3H/HeJ thymic  responder cells used in  all 
proliferation assays were LPS unresponsive, as ascer- 
tained  in  control  experiments  (data not shown]. 
TCFl  preparations from Con-A pulsed spleen cells con- 
tained IFN--/. Therefore, recombinant IFN--/ was tested 
for induction of proliferative responses  in  the  presence 
of IL 2. IFN-y, however, in concentrations from 4 to 286 
U, did not  induce IL 2-dependent proliferation (Table I]. 
Thus, both IL 1 and  TCFl induced IL 2-dependent  thy- 
mocyte proliferation. 
Thymocyte target cells for TCF1-induced IL 2-de- 
pendent cytotoxicity and proliferation. C3H/HeJ thy- 
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Figure 1.  Requirement of TCFl in excess IL 2 for the induction of 
cytotoxic responses of thymocytes. Cytotoxic responses  were  measured 
or purified IL 1 (40 U/ml) (0) without [--) or in  combination  with 20 pl of 
in  cultures  that  contained  TCFl m), recombinant IFN-y (160 U/ml) (A), 
recombinant IL 2 (400  U/ml) (-). 
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Proliferation of 5 x lo5 C3H/HeJ thymocytes  induced  with  either  TCFl 
Figure2 Induction of thymocyte proliferation with TCFl and IL 2. 
from K 15 T  hybridoma  cells (.) or purified IL 1 (2 U/ml) (0) in  the  presence 
of 50 pl  of recombinant IL 2 (100 U/ml). 3H-TdR uptake  with  TCFl or IL 
1  alone, <500 cpm; 'H-TdR uptake  with 1L 2  alone,  4240  cpm. 
mocytes were stained with subagglutinating doses of 
PNA-FITC and  separated with  a cell sorter  into a PNA+ 
and a PNA- fraction  (24).  Reanalysis of the viable sorted 
thymocytes showed >95% PNA- cells with  a  mean fluo- 
rescence intensity of 46  and >97% PNA+ cells with a 
mean fluorescence intensity of 533. respectively. The 
data in Table I1 show that TCFI-induced cytotoxicity as 
well as  proliferation in  presence of IL 2 is only seen with 
the PNA- fraction of the separated  thymocytes. Compa- 
rable cytotoxic responses were found  with  one-fourth the 
number of  PNA- cells compared  with  unfractionated  thy- 
mocytes. The PNA+ cells did not  respond to  the indicated 
stimuli with cytotoxicity or proliferation. IL 2 alone  was 
able to induce  a proliferative response in the PNA- pop- 
TABLE I 
Lack of synergy of IFN-Y and IL 2 in  induction of thymocyte 
prollferation" 
Additlon  to  Cultures 
IL 2 (U/ml) 
0 20 40 
Medium 100 560 
IFN 280 U/ml 110 
760 
780 
140 U/ml 
640 
100 
70 U/ml 
690 
140  940 
990 
35 U/ml 
730 
110 780 800 
17 U/ml 110 
9 U/ml 60 
490 
760 
520 
4 U/ml 60 
840 
390 
TCF 1 130 8.330 10.120 
910 
"C3H/HeJ thymocytes (2 x IO5) were cultured in the presence of 
various amounts of partially purified IL 2 in 0.2 ml volume. Various 
amounts of recombinant IFN-y or a TCFl  preparation  from Con A-pulsed 
spleen  cells (50 PI) were  added  to  the  cultures. 3H-TdR uptake  was  mea- 
sured  in a 5-hr  pulse on day 3. Data are cpm. 
TABLE I1 
TCF1-induced prollferation  and  cytotoxicity of thymic 
subpopulatlons 
Thymocytes 
Additlon  to 'H-TdR Uptake 
Culturesa lcom x 10+1 % Speclfic 51Cr Release . .  
Unsorted PNA- PNA' Unsorted PNA- PNA+ 
IL 2 7.7 16.6  1.2 0.0 0.0' 0.0 
TCF 1 
Con A 
26.4  1.5  2.0  0.6 0.0 0.0 
1.2 NTb 0.8 NT  NT  NT 
IL 2 + TCFl 
IL 2 + Con A 85.8 141.8  2.3 NT  NT NT
70.3 79.4  2.9 15.5 19.6 0.0 
contained recombinant human IL 2 (20 U/ml) and/or TCFl from K15 
"Cultures of IO' unseparated or PNA- or PNA+ C3H/HeJ thymocytes 
cells (25 p1) and/or Con A (1 p g h l ) .  
e PNA- thymocytes  (2.5 X lo4) were  cultured  for  induction of cytotox- 
NT = not  tested. 
icity. 
ulation. However, this response was small (21%) com- 
pared  with the synergistic effect of TCFl and IL 2 and 
might be due to some preactivated cells. 
Distinction of TCFI- from IL 1-induced thymocyte 
proliJeration. Both IL 1 and TCFl induced thymocyte 
proliferation in the presence of IL 2 (see Figure 2). We 
used the above lymphokine  preparations together with 
the T cell mitogen Con A to  induce thymocyte prolifera- 
tion. Figure 3 shows that  the TCFl  dose-response  curve 
paralleled the dose response of the IL 1 preparation.  Thus 
both purified IL 1 (from  macrophages and from the cell 
line P388D1) and  TCFl (from T hybridoma K15) stimu- 
lated thymocyte proliferation in  the presence of subopti- 
mal amounts of mitogen (Con A). 
Antibodies directed against IL 1 were able to distin- 
guish between the two cytokines  (Table 111). IL 1-induced 
but not  TCFl-induced  proliferation  was  inhibited (80% 
and  94%) with  a 1/10 dilution of the anti-IL 1  antiserum. 
We have  preliminary evidence that IL 1 and TCFl  can 
also be distinguished  with sugars as inhibitors of TCFl- 
induced proliferation and cytotoxicity (to be published). 
TCFl induces IL 2 receptor expression in the pres- 
ence of IL 2. Induction of IL 2 receptor expression could 
be the reason for the  TCFl-induced IL 2-dependent pro- 
liferative response of thymocytes. Monoclonal antibodies 
(AMT 13) directed against  the  murine IL 2 receptor (24) 
were utilized to  measure  the  amount of IL 2 receptor on 
the cell surface. Table IV shows that AMT 13-binding 
was  greater  when cells were cultured with TCFl  plus IL 
2 than when  cultured  with IL 2, TCFl, or IFN-7 alone. 
Addition of IL 2  shortly before the  assays did not  increase 
binding of  AMT 13 to the IL 2 receptor (data not shown). 
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induce cytotoxic responses of thymocytes  in the presence 
of IL 2  (7). The activities of IL 1 and TCFl  differ  in two 
100 I 
X 
€9 
pl per Culture 
Figure3. Synergy of TCFl  and IL 1  with Con A in  Induction of thy- 
mocyte  proliferation.  C3H/HeJ  thymocytes (5 X lo5) were  cultured  with 
or without Con A (1 Ilg/ml] in  0.2 ml medium. The cultures contained 
serial twofold dilutions of either IL 1 (from  P388DI) (0) or TCFl  (from the 
T cell hybridoma K15) (r). 3H-TdR uptake  was  measured  in a 5-hr pulse 
on day  3. 
TABLE  Ill 
Effect of anti-ll 1 antibodies on IL 1 - and TCFl -induced  thymocyte 
prolferation" 
~- - - - 
Addition to Dilutlon of Antl-IL 1 Antibodies 
Cultures - 
a] 1L 1 
b) IL 1 
1/1000 1/100 1/10 
171.6  156.4 (91 100.7(41] 10.5 (94) 
TCF 1 
154.0  158.4 (0) 117.3(24)  30.5(80) 
231.0  2 7.4 (10) 217.8  (10)  200.2  (13) 
"C3H/HeJ thymocytes (3 X lo5) were cultured in the presence of 
recombinant human IL 2 (20 U/ml) in 0.2 ml medium. The cultures 
contained  purified IL 1 (a) (2 U/ml), partially  purified IL 1  (b)  (2 U/ml). or 
TCFl from K15  T  hybridoma  cells (25 p l )  and/or  various  concentrations 
of anti-iL  1  antibodies. 3H-TdR uptake  was  measured  in a 10-hr  pulse  on 
day 3. Values are cpm X lo-? numbers  in  parentheses  are  percent of 
inhibition. 
TABLE IV 
Induction of IL 2  receptor  expression on thymocytes 
~"
Addition to Culture8 
AMT 13 Bindin$ 
Icvrnl 
Medium 2.250 
IL 2 5.480 
iFN-y 
TCF 1 
1,590 
7,880 
TCFl + IL 2 
4.470 
20.780 
Con A supernatant  145.680 
. .  . 
IFN-) + 1L 2 
respects:  1)  TCFl , but not IL 1,  shows a synergistic  helper 
effect in the development of  CTL from help-deficient 
thymocyte cultures. 2) A highly specific  antibody  to IL 1 
inhibits the IL 2-dependent proliferative response of thy- 
mocytes induced by IL 1 but not by TCFl . 
The target  cells of TCFl  and IL 1 are  the  mature PNA- 
thymocytes. Whether TCFl acts directly on medullary 
thymocytes  or  whether  immature  thymocytes from the 
cortex are recruited  into the lymphokine reactive cell pool 
remains to be studied. It is also unclear how IL 1 and 
TCFl  induce IL 2  receptor  expression in synergy with IL 
2. IL 1,  TCFl, or IL 2  alone, however, do not  induce IL 2 
receptor expression. There are technical limitations to 
these assays. Significant proliferation and cytotoxicity 
requires 24  to  48  hr of coincubation  with  TCFl and IL 2 
(8). In the  absence of IL 2, most of the cells were dead 
after  that time. It may be that TCFl is sufficient for IL 2 
receptor expression and  that IL 2 only guarantees cell 
survival. With the method used we cannot  answer  this 
question. I t  may be that IL 1 or  TCFl "prime" the respon- 
sive T cell for IL 2 receptor expression, which is then 
brought  about by IL 2 itself giving the second signal. This 
suggests  a regulatory role of IL 2  for  expression of its own 
receptor. This hypothesis is supported by the  fact  that 
human IL 2 can regulate the expression of the Tac anti- 
gen  on  human T  cells  (27,  28).  Other  stimuli that lead to 
expression of IL 2  receptors are receptor-inducing  factor 
(29, 30) and antigen  (31-34).  Whether IL 2 receptor in- 
duction by factors  or  antigen  are  separate  events or seg- 
ments of the  mechanism by which this induction is ac- 
complished in vivo remains to be shown. Also, the  ques- 
tion remains why two cytokines (IL 1, TCF 1)  with  similar 
effects  on the IL 2  receptor  expression  exist. It is conceiv- 
able that IL 1 and TCFl  stimulate  different  subsets of 
PNA- cells. This would also  explain why the combined 
action of IL 1 and IL 2  leads only to proliferation,  whereas 
the synergistic  effect of TCFl  and IL 2  leads to prolifer- 
ation and cytotoxicity. The  simplest,  but  unproven, ex- 
planation would be that IL 1  induces IL 2  responsiveness 
in helper T cell precursors,  whereas  TCFl  induces  the 
same effect in CTLp. These  questions  can only be an- 
swered  with  sufficient  quantities of the pure  cytokines 
tested in limiting  dilution  cultures on clones of thymocyte 
helper T cells and CTLp. 
Acknowledgments. We thank Brigitte Sonsky and 
Yvonne Rath for  expert  technical assistance, Dr. Peter 
Robinson for critical reading of the manuscript, and 
Jutta Rami for manuscript  preparation. 
nant IFN-y (140 U/ml). TCFl  from K15 T  hybridoma  cells (10%). and/or 
Forty-eight-hour  cultures of 2 x 10' thymocytes  contained recombi- 
partially  purified IL 2 (40 U/ml) or Con A supernatant  (30%). 
bSpecific binding of monoclonal antibodies (AMT 13) (25) directed 
against the murine IL 2 receptor was measured on 4 x 10' cells per 
sample. 
DISCUSSION 
We recently  described the synergistic effect of purified 
IL 1 and recombinant IL 2 in the induction of IL 2 receptor 
expression  on  thymocytes  (26). In this  report, we present 
data suggesting that TCFl has similar  effects  on thymo- 
cytes. TCFl activity is characterized by its ability to 
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